Low sex hormone-binding globulin and testosterone levels in association with erectile dysfunction among human immunodeficiency virus-infected men receiving testosterone and oxandrolone

被引:7
|
作者
Wasserman, Peter [1 ]
Segal-Maurer, Sorana [1 ]
Rubin, David [1 ]
机构
[1] New York Hosp Queens, Dept Med, Div Infect Dis, Flushing, NY 11367 USA
关键词
oxandrolone; sex hormone-binding globulin; human immunodeficiency virus;
D O I
10.1111/j.1743-6109.2007.00634.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Introduction. Men with acquired immunodeficiency syndrome (AIDS) wasting and hypogonadism are frequently treated with testosterone and oxandrolone, an orally administered anabolic-androgenic steroid hormone. We observed reductions in testosterone and sex hormone-binding globulin (SHBG) levels, in association with complaints of erectile dysfunction, after prolonged exposure to this therapeutic regimen. Aim. First description of an association between long-term receipt of oxandrolone with erectile dysfunction, low SHBG and testosterone. Methods. Case report of three human immunodeficiency virus-infected hypogonadal male patients receiving treatment for wasting syndrome and hypogonadism, and highly active antiretroviral therapy. All three patients received long-term oxandrolone in addition to testosterone replacement therapy. Results. Testosterone and SHBG levels for patients 1, 2, and 3, respectively: total testosterone 183, 71, and 151 ng/dL (260-1,000 ng/dL); free testosterone (not done for patient 3) 58.3 and 26.9 pg/mL (50-210 pg/mL); SHBG 6, 9, and 6 nmol/L (7-50 nmol/L). No other hormonal abnormalities were detected. Following discontinuation of oxandrolone, levels of total testosterone rose, consistent with increase in SHBG. One patient received repeat SHBG assay documenting rise in SHBG level. Patient 2 reported return of libido and early morning erections several weeks after discontinuation of oxandrolone. Conclusions. Patients had erectile dysfunction in association with low testosterone and SHBG, in spite of exogenous testosterone replacement. Discontinuation of oxandrolone led to the normalization or improvement of testosterone levels in all three patients with symptomatic improvement in one patient. First pass metabolism of orally administered oxandrolone may decrease hepatic synthesis of SHBG, allowing exogenously supplied testosterone to be excreted. Further work is necessary to elucidate the relationship.
引用
收藏
页码:241 / 247
页数:7
相关论文
共 43 条
  • [21] The C282Y polymorphism of the hereditary hemochromatosis gene is associated with increased sex hormone-binding globulin and normal testosterone levels in men
    Yeap, B. B.
    Beilin, J.
    Shi, Z.
    Knuiman, M. W.
    Olynyk, J. K.
    Chubb, S. A. P.
    Bruce, D. G.
    Milward, E. A.
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2010, 33 (08) : 544 - 548
  • [22] The C282Y polymorphism of the hereditary hemochromatosis gene is associated with increased sex hormone-binding globulin and normal testosterone levels in men
    B. B. Yeap
    J. Beilin
    Z. Shi
    M. W. Knuiman
    J. K. Olynyk
    S. A. P. Chubb
    D. G. Bruce
    E. A. Milward
    Journal of Endocrinological Investigation, 2010, 33 : 544 - 548
  • [23] Endogenous circulating testosterone and sex hormone-binding globulin levels and measures of myocardial structure and function: the Framingham Heart Study
    Pencina, K. M.
    Travison, T. G.
    Bhasin, S.
    Li, Z.
    Nigam, N.
    Manning, W. J.
    Vasan, R. S.
    Hoffmann, U.
    O'Donnell, C. J.
    Basaria, S.
    ANDROLOGY, 2019, 7 (03) : 307 - 314
  • [24] Cross-sectional association between testosterone, sex hormone-binding globulin and metabolic syndrome: The Healthy Twin Study
    Moon, Heesun
    Choi, Inyoung
    Kim, Somi
    Ko, Hyeonyoung
    Shin, Jinyoung
    Lee, Kayoung
    Sung, Joohon
    Song, Yun-Mi
    CLINICAL ENDOCRINOLOGY, 2017, 87 (05) : 523 - 531
  • [25] Total testosterone and sex hormone-binding globulin are associated with metabolic syndrome independent of age and body mass index in Korean men
    Hong, Doohee
    Kim, Young-Sang
    Son, Eun Soo
    Kim, Kyu-Nam
    Kim, Bom-Taeck
    Lee, Duck-Joo
    Kim, Kwang-Min
    MATURITAS, 2013, 74 (02) : 148 - 153
  • [26] Low levels of sex hormone-binding globulin and hyperproinsulinemia as markers of increased pancreatic β-cell demand in men
    Reis, AF
    Miranda, WL
    Chacra, AR
    BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, 1998, 31 (12) : 1545 - 1551
  • [27] Testosterone replacement therapy: Pre-treatment sex hormone-binding globulin levels and age may identify clinical subgroups
    Ramachandran, Sudarshan
    Hackett, Geoffrey, I
    Strange, Richard C.
    ANDROLOGY, 2020, 8 (05) : 1222 - 1232
  • [28] Longitudinal changes in serum testosterone and sex hormone-binding globulin in men aged 40-69 years from the UK Biobank
    Marriott, Ross J.
    Murray, Kevin
    Hankey, Graeme J.
    Manning, Laurens
    Dwivedi, Girish
    Wu, Frederick C. W.
    Yeap, Bu B.
    CLINICAL ENDOCRINOLOGY, 2022, 96 (04) : 589 - 598
  • [29] SEX-DIFFERENCES IN UMBILICAL-CORD SERUM LEVELS OF INHIBIN, TESTOSTERONE, ESTRADIOL, DEHYDROEPIANDROSTERONE-SULFATE, AND SEX HORMONE-BINDING GLOBULIN IN HUMAN TERM NEONATES
    SIMMONS, D
    FRANCE, JT
    KEELAN, JA
    SONG, L
    KNOX, BS
    BIOLOGY OF THE NEONATE, 1994, 65 (05): : 287 - 294
  • [30] The association of testosterone, sex hormone-binding globulin, and insulin-like growth factor-1 with bone parameters in Korean men aged 50 years or older
    Hye-Jung Kim
    Hyung Suk Koo
    Young-Sang Kim
    Moon Jong Kim
    Kwang-Min Kim
    Nam-Seok Joo
    Ji-hee Haam
    Journal of Bone and Mineral Metabolism, 2017, 35 : 659 - 665